Abstract
Aim
The aim of this study is to determine accurately the localization of the adenoma with the imaging methods in the patients, who are planned to be operated on with prediagnosis of parathyroid adenoma.
Method
In our study, the files of the patients who were considered to have parathyroid adenoma and underwent operation between 2012 and 2020 with the methods such as Tc99m-MIBI SPECT/CT, 18F-fluorocholine PET/CT, and ultrasound, and biochemical examinations were examined retrospectively.
Results
In this study, 31 (18.2%) male and 139 (81.8%) female adult patients were included. The sensitivities of localization methods were 82.6% for ultrasound and 78.4% for scintigraphy. Adenoma was localised in the right place in 14 of 15 (93.3%) patients with the 18F-fluorocholine PET/CT method. A statistically significant correlation was found between the sensitivity of scintigraphy, the gland weights (p: 0.002), and phosphor values (p: 0.039). A statistically significant improvement was observed in the intact PTH value (p: 0.001) 15 min after the removal of adenoma. A statistically significant improvement was observed in the serum PTH value (p: 0.001), the serum phosphorus value (p: 0.001), and the serum calcium (p: 0.001) in the first 3 months after the operation.
Conclusion
Determining localization accurately for the patients enables performing operations with minimally invasive surgery successfully in a shorter time. Also, fewer complications and faster recovery are seen in the patients. It was concluded that studying intraoperative intact PTH and using 18F-fluorocholine PET/CT method for localization give more accurate results for localization and allow having more successful operation outcomes.
Similar content being viewed by others
References
Schwartz’s principles of surgery, 10th edition (2016) McGraw Hill Education, 1556–1574
Bilezikian JP, Bandeira L, Khan A et al (2018) Hyperparathyroidism. Lancet Lond Engl 391:168–78
Bilezikian JP, Silverberg SJ (2000) Clinical spectrum of primary hyperparathyroidism. Rev Endocr Metab Disord 1:237–245
Correa P, Lundgren E, Rastad J et al (2002) MEN I polymorphismD418D is associated with sporadic primary hyperparathroidism. Surgery 132(3):450–455
Talpos GB, Bone GH, Kleerekoper M et al (2000) Randomized trial of parathyroidectomy in mild asyptomatic primary hyperparathyroidism: patient description and effects on the SF-36 Healty survey. Surgery 128(6):1013–1020
Bilezikian JP, Potts JT, Fuleiham Gel-H et al (2002) Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21 st century. J Clin Endocrinol Metab 87:5353–5361
Lepage R, Roy L, Brossard JH et al (1998) A non-(1-84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples. Clin Chem 44:805-9
Gao P, D’Amour P (2005) Evolution of the parathyroid hormone (PTH) assay–importance of circulating PTH immunoheterogeneity and of its regulation. Clin Lab 51:21–29
Murray TM, Rao LG, Divieti P et al (2005) Parathyroid hormone secretion and action: evidence for discrete receptors for the carboxyl-terminal region and related biological actions of carboxyl- terminal ligands. Endocr Rev 26(1):78 (PMID: 15689574)
Nussbaum SR, Zahradnik RJ, Lavigne JR et al (1987) Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. Clin Chem 33(8):1364
Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl. 2009 Aug;(113):S1-130. https://doi.org/10.1038/ki.2009.188. PMID: 19644521
Neumann DR, Esselstyn CB, MacIntyre WJ et al (1996) Comparison of FDG-PET and sestamibi-SPECT in primary hyperparathyroidism. J Nucl Med 37:1809–1815
Sundin A, Johansson C, Hellman P et al (1996) PET and parathyroid L-(C-11)- methionine accumulation in hyperparathyroidism. J Nucl Med 37:1766–1770
Mohsen B, Lukas H, Zeinab P et al (2018) 18F-Fluorocholine PET/CT in the assessment of primary hyperparathyroidism compared with 99mTc-MIBI or 99mTc-tetrofosmin SPECT/CT: a prospective dual-centre study in 100 patients. Eur J Nucl Med Mol Imaging 45(10):1762–1771
Flynn MB, Bumpous JM, Schill K et al (2000) Minimally invasive radioguided parathyroidectomy. J Am Coll Surg 191:24–31
Batool S, Shakeel O, Urooj N et al (2019) JPMA J Pak Med Assoc 69:1205–1208
Cheung K, Wang TS, Farrokhyar F et al (2012) A meta-analysis of preoperative localization techniques for patients with primary hyperparathyroidism. Ann Surg Oncol 19:577–583
Agha A, Hornung M, Schlitt HJ et al (2014) The role of contrast-enhancend ultrasonography (CEUS) in comparison with 99mTechnetium-sestamibi scintigraphy for localization diagnostic of primary hyperparathyroidism. Clin Hemorheol Microcirc 58:515–520
Fatima T, Das B, Sattar S et al (2021) The utility of ultrasound in the preoperative localization of primary hyperparathyroidism: insights from Pakistan. Cureus [Internet]. Website: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496491/
Acín-Gándara D, Pereira-Pérez F, Medina-García M, Sebastián-Viana T (2020) Factors infuencing the sensitivity of ultrasound and gamma localization of the parathyroid adenoma. Cirugia Espanola 98:18–25
Ruda JM, Hollenbeak CS, Stack BC (2005) A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngol Head Neck Surg 132:359–372
Winters R, Friedlander P, Noureldine S et al (2011) Preoperative parathyroid needle localization: a minimally invasive novel technique in reoperative settings. Minim Invasive Surg 2011:487076
Beheshti M, Hehenwarter L, Paymani Z et al (2018) (18)F-Fluorocholine PET/CT in the assessment of primary hyperparathyroidism compared with (99m)Tc-MIBI or (99m)Tc-tetrofosmin SPECT/CT: a prospective dual-centre study in 100 patients. Eur J Nucl Med Mol Imaging 45(10):1762–1771. https://doi.org/10.1007/s00259-018-3980-9
Thanseer N, Bhadada SK, Sood A et al (2017) Comparative effectiveness of ultrasonography, 99mTc-Sestamibi, and 18F-fluorocholine PET/CT in detecting parathyroid adenomas in patients with primary hyperparathyroidism. Clin Nucl Med 42(12):e491–e497
Cuderman A, Senica K, Rep S et al (2020) 18F-fluorocholine PET/CT in primary hyperparathyroidism: superior diagnostic performance to conventional scintigraphic imaging for localization of hyperfunctioning parathyroid glands. J Nucl Med 61(4):577–583. https://doi.org/10.2967/jnumed.119.229914
Glenn JA, Yen TW, Javorsky BR et al (2016) Association between body mass index and multigland primary hyperparathyroidism. J Surg Res 202(1):132–8
Pallan S, Rahman MO, Khan AA (2012) Diagnosis and management of primary hyperparathyroidism. BMJ 344:e1013
Madkhali T, Alhefdhi A, Chen H, Elfenbein D (2016) Primary hyperparathyroidism. Turk J Surgery 32:58–66
Nishiyama RH, Farhi D, Thompson NW (1979) Radiation exposure and the simultaneous occurrence of primary hyperparathyroidism and thyroid nodules. Surg Clin North Am 59(1):65–75.
Fedorak IJ, Salti G, Fulton N et al (1994) Increased incidence of thyroid cancer in patients with primary hyperparathyroidism: a continuing dilemma. Am Surg 60(6):427–431
Morita SY, Somervell H, Umbricht CB et al (2008) Evaluation for concomitant thyroid nodules and primary hyperparathyroidism in patients undergoing parathyroidectomy or thyroidectomy. Surgery 144(6):862–867
Kosem M, Algun E, Kotan C et al (2004) Coexistent thyroid pathologies and high rate of papillary cancer in patients with primary hyperparathryoidsm cotroversies about minimal invasive parathyroid surgery. Acta chir belg 104:568–571
Usman A, Sayek I (1996) Paratiroidler ve Hastalıkları. Temel Cerrahi Kitabı 2(139):1584–1605
Rossi RL, Cady B (1991) Surgery of parathyroid glands. In: Cady B, Rossi RL (eds) Surgery of the Thyroid and Parathyroid Glands. WB Saunders, Philadelphia, pp 283–294
Wang CA (1981) Hyperfunctioning intra-thyroid parathyroid gland. A potential cause of failure in parathyroid surgery. JR Soc Med 74: 49–54
Shen W, Duren M, Morita E (1996) Reoperation for persistent or recurrent primary hyperparathyroidism. Arch Surg 131:861–867
Eigelberger MS, Clark OH (2000) Surgical approaches to primary hyperparathyroidism. Endoc and Metab Clin of North Am 29:479–502
Irwin GL, Dembrow VD, Prudhomme DL (1993) Clinical usefulness of an intraoperative quick parathyroid hormone assay. Surgery 114:1019–1024
Khan ZF, Lew JI (2019) Intraoperative parathyroid hormone monitoring in the surgical management of sporadic primary hyperparathyroidism. Endocrinol Metab 34:327–339
Phillips IJ, Kurzawinski TR, Honour JW (2005) Potential pitfalls in intraoperative parathyroid hormone measurements during parathyroid surgery. Ann Clin Biochem 42:453–458
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical approval
The ethics committee approval of Gaziantep University Medical Faculty was obtained (17.10.2020, No: 2020/331).
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Bilen, N., Gokalp, M.A., Yilmaz, L. et al. Analysis of intraoperative laboratory measurements and imaging techniques such as Tc-99 m-MIBI SPECT/CT, 18F-fluorocholine PET/CT and ultrasound in patients operated with prediagnosis of parathyroid adenoma. Ir J Med Sci 192, 1695–1702 (2023). https://doi.org/10.1007/s11845-022-03215-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11845-022-03215-3